BRCA1 and neoplasm: To extend these data to expression of the survival factors AKT1, AKT2, p-AKT, and survivin, adjacent sections from each tumor were immunohistochemically stained with BRCA1-IRIS, AKT1, AKT2, p-AKT, survivin, and BRCA1/p220 antibodies.